Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Theravance names Michael Aguiar CEO

This article was originally published in Scrip

Executive Summary

San Francisco, California-based Theravance Inc has appointed Michael W Aguiar as president and chief executive officer of the company effective 15 August, and as a member of its board of directors effective immediately. Mr Aguiar will replace Rick E Winningham who has resigned as CEO of Theravance Inc. Mr Winningham will however remain chair of Theravance's board and transition to full time CEO of spin out unit Theravance Biopharma.

Table

View full table

Related Companies

Tags:
Latest Headlines

Astellas Stakes Claim In CAR-Ts For Solid Tumors With Poseida Deal

Pharma Happy To Be Custodian For Innovative Science From Cash-Strapped Biotechs

GSK Looks Forward To RSV Vaccine Competition

Syngene Chief: Large Cap Biopharma Taking China 'Rotation' More Seriously

See All
UsernamePublicRestriction

Register

SC026080

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By